DEXAMETHASONE PRESERVATIVE FREE eye drops solution

DEXAMETHASONE PRESERVATIVE FREE eye drops solution
Product Description

Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA)

Read more Show less

Rafarm S.A

  • Country/Region:
    Greece
  • On CPHI since:
    2015
View company profile

Rafarm S.A

  • Country/Region:
    Greece
  • On CPHI since:
    2015
View company profile

More Products from Rafarm S.A (38)

  • AMIKACIN solution for injection

    Product AMIKACIN solution for injection

    Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin 
  • ATORVASTATIN f.c. tablets

    Product ATORVASTATIN f.c. tablets

    Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer)
  • BIMATOPROST + TIMOLOL eye drops solution

    Product BIMATOPROST + TIMOLOL eye drops solution

    Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan)
  • BIMATOPROST eye drops solution

    Product BIMATOPROST eye drops solution

    Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan)
  • BRIMONIDINE + TIMOLOL eye drops solution

    Product BRIMONIDINE + TIMOLOL eye drops solution

    Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)
  • BRIMONIDINE eye drops solution

    Product BRIMONIDINE eye drops solution

    Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan)
  • DEXAMETHASONE soluble tablets

    Product DEXAMETHASONE soluble tablets

    Strength:  0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-)
  • DONEPEZIL f.c. tablets

    Product DONEPEZIL f.c. tablets

    Strength: 5 mg/tab; 10 mg/tab Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DONEPEZIL oral solution

    Product DONEPEZIL oral solution

    Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)
  • DORZOLAMIDE + TIMOLOL eye drops solution

    Product DORZOLAMIDE + TIMOLOL eye drops solution

    Strength: (20 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Cosopt (Merk & Co)
  • DORZOLAMIDE eye drops solution

    Product DORZOLAMIDE eye drops solution

    Strength: 20 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Trusopt (Merk & Co)
  • DUTASTERIDE soft gel capsules

    Product DUTASTERIDE soft gel capsules

    Strength: 0.5 mg/cap Therapeutic area: Benign Prostatic Hyperplasia Innovator: Avodart (GSK)
show all 38 other products